3D nuclear organization of telomeres in the Hodgkin cell lines U-HO1 and U-HO1-PTPN1: PTPN1 expression prevents the formation of very short telomeres including "t-stumps"

BMC Cell Biology

Volumn 11, Issue , 2010, Pages

  Knecht, Hans ^a   Brüderlein, Silke ^b   Wegener, Silke ^c   Lichtensztejn, Daniel ^d   Lichtensztejn, Zelda ^d   Lemieux, Bruno ^a   Möller, Peter ^b   Mai, Sabine ^d  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^b UNIVERSITY OF ULM   (Germany)

^c St Elisabeth Hospital   (Germany)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE 1B; STAT5A PROTEIN; TELOMERASE; PTPN1 PROTEIN, HUMAN; STAT5 PROTEIN; STAT5A PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL FUNCTION; CELL METABOLISM; CELL TYPE; CHROMOSOME SIZE; CHROMOSOME STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FLUORESCENCE IN SITU HYBRIDIZATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOMA CELL LINE; NUCLEOTIDE SEQUENCE; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REED STERNBERG CELL; STABLE EXPRESSION; TELOMERE; THREE DIMENSIONAL IMAGING; CELL LINE; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; PATHOLOGY; ULTRASTRUCTURE;

APOPTOSIS; CELL LINE; G2 PHASE; HODGKIN DISEASE; HUMANS; IMAGING, THREE-DIMENSIONAL; IN SITU HYBRIDIZATION, FLUORESCENCE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; PROTO-ONCOGENE PROTEINS C-AKT; REED-STERNBERG CELLS; STAT5 TRANSCRIPTION FACTOR; TELOMERASE; TELOMERE; TUMOR SUPPRESSOR PROTEINS;

EID: 78649911136     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-11-99     Document Type: Article

References (33)

1. Hsu SM, Zhao X, Chakraborty S, Liu YF, Whang-Peng J, Lok MS, Fukuhara S. Reed-Sternberg cells in Hodgkin's cell lines HDLM-2, L-428, and KM-H2 are not actively replicating: lack of bromodeoxyuridine uptake by multinuclear cells in culture. Blood 1988, 71:1382-1389.
2. Drexler HG, Gignac SM, Hoffbrand AV, Minowada J. Formation of multinucleated cells in a Hodgkin's-disease-derived cell line. Int J Cancer 1989, 43:1083-1090. 10.1002/ijc.2910430622, 2659541.
3. Newcom SR, Kadin ME, Phillips C. L-428 Reed-Sternberg cells and mononuclear Hodgkin's cells arise from a single cloned mononuclear cell. Int J Cell Cloning 1993, 6:417-431.
4. Knecht H, Sawan B, Lichtensztejn D, Lemieux B, Wellinger RJ, Mai S. The 3D nuclear organization of telomeres marks the transition from Hodgkin to Reed-Sternberg cells. Leukemia 2009, 23:565-573. 10.1038/leu.2008.314, 19039323.
5. Louis SF, Vermolen BJ, Garini Y, Young IT, Guffei A, Lichtensztejn Z, Kuttler F, Chuang TC, Moshir S, Mougey V, Chuang AY, Kerr PD, Fest T, Boukamp P, Mai S. c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc Natl Acad Sci USA 2005, 102:9613-9618. 10.1073/pnas.0407512102, 1172233, 15983382.
6. Knecht H, Sawan B, Lichtensztejn Z, Lichtensztejn D, Mai S. 3D telomere FISH defines LMP1 expressing Reed-Sternberg cells as end-stage cells with telomere-poor "ghost" nuclei. Lab Invest 2010, 90:611-619. 10.1038/labinvest.2010.2, 20142802.
7. Mader A, Brüderlein S, Wegener S, Melzner I, Popov S, Muller-Hermelink HK, Barth TF, Viardot A, Möller P. U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma. Cytogenet Genome Res 2007, 119:204-210. 10.1159/000112062, 18253030.
8. Wegener S, Mader A, Melzner I, Brüderlein S, Möller P. Lack of PTPN1 (PTP1B) in U-HO1, a new Hodgkin-derived cell line, protects cells from apoptosis. Haematologica 2007, 92(s5):39.
9. Aoki N, Matsuda T. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphory-lates and deactivates prolactin-activated STAT5a aand STAT5b. J Biol Chem 2000, 275:39718-39726. 10.1074/jbc.M005615200, 10993888.
10. Scheeren FA, Naspetti M, Diehl S, Schotte R, Nagasawa M, Wijnands E, Gimeno R, Vyth-Dreese FA, Blom B, Spits H. STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression. Nat Immunol 2005, 6:303-313. 10.1038/ni1172, 15711548.
11. Hinz M, Lemke P, Anagnostopoulos I, Hacker C, Krappmann D, Mathas S, Dörken B, Zenke M, Stein H, Scheidereit C. Nuclear factor kB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J Exp Med 2002, 196:605-617. 10.1084/jem.20020062, 2194004, 12208876.
12. Scheeren FA, Diehl SA, Smit LA, Beaumont T, Naspetti M, Bende RJ, Blom B, Karube K, Ohshima K, van Noesel CJ, Spits H. IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis. Blood 2008, 111:4706-4715. 10.1182/blood-2007-08-105643, 2343600, 18296629.
13. Dubé N, Bourdeau A, Heinonen KM, Cheng A, Lee Loy A, Tremblay ML. Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p53-Null mice through the regulation of B-cell development. Cancer Res 2005, 65:10088-10095. 10.1158/0008-5472.CAN-05-1353, 16267035.
14. Heinonen KM, Dubé N, Bourdeau A, Lapp WS, Tremblay ML. Protein tyrosine phosphatase 1B negatively regulates macrophage development through CSF-1 signaling. Proc Natl Acad Sci USA 2007, 103:2776-2781.
15. Khan G. Epstein-Barr virus, cytokines, and inflammation: A cocktail for the pathogenesis of Hodgkin's lymphoma?. Exp Hematol 2006, 34:399-406. 10.1016/j.exphem.2005.11.008, 16569586.
16. Xu L, Blackburn EH. Human cancer cells harbour T-stumps, a distinct class of extremely short telomeres. Mol Cell 2007, 28:315-327. 10.1016/j.molcel.2007.10.005, 2081152, 17964269.
17. De Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Gene Dev 2005, 19:2100-2110. 10.1101/gad.1346005, 16166375.
18. MacLeod RA, Spitzer D, Bar-Am I, Sylvester JE, Kaufmann M, Wernich A, Drexler HG. Karyotypic dissection of Hodgkin's disease cell lines reveals ectopic subtelomeres and ribosomal DNA at sites of multiple jumping translocations and genomic amplification. Leukemia 2000, 14:1803-1814. 10.1038/sj.leu.2401894, 11021756.
19. Guffei A, Sarkar R, Klewes L, Righolt C, Knecht H, Mai S. Dynamic chromosomal rearrangements in Hodgkin's lymphoma are due to ongoing 3D nuclear remodelling and breakage-bridge-fusion cycles. Haematologica 2010, 95:2038-2046. 10.3324/haematol.2010.030171, 20823137.
20. Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, Dörken B. Constitutive nuclear factor-kappaB-RelA activtion is required for profliferation and survival in Hodgkin's disease tumor cells. J Clin Invest 1997, 100:2961-2969. 10.1172/JCI119849, 508507, 9399941.
21. Weniger MA, Melzner I, Menz CK, Wegener S, Bucur AJ, Dorsch K, Mattfeldt T, Barth TF, Möller P. Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation. Oncogene 2006, 25:2679-2684. 10.1038/sj.onc.1209151, 16532038.
22. Harir N, Pecquet C, Kerenyi M, Sonneck K, Kovacic B, Nyga R, Brevet M, Dhennin I, Gouilleux-Gruart V, Beug H, Valent P, Lassoued K, Moriggl R, Gouilleux F. Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias. Blood 2007, 109:1678-1686. 10.1182/blood-2006-01-029918, 17038539.
23. Kandel ES, Skeen J, Majewski N, Di Cristofano A, Pandolfi PP, Feliciano CS, Gartel A, Hay N. Activation of Akt/protein kinase B overcomes a G2/M cell cycle checkpoint induced by DNA damage. Mol Cell Biol 2002, 22:7831-7841. 10.1128/MCB.22.22.7831-7841.2002, 134727, 12391152.
24. Hixon ML, Muro-Cacho C, Wagner MW, Obejero-Paz C, Millie E, Fujio Y, Kureishi Y, Hassold T, Walsh K, Gualberto A. Akt1/PKB upregulation leads to vascular smooth muscle cell hypertrophy and polyploidization. J Clin Invest 2000, 106:1011-1020. 10.1172/JCI8252, 314338, 11032861.
25. Tiganis T, Bennett AM. Protein tyrosine phosphatase function: the substrate perspective. Biochem J 2007, 402:1-15. 10.1042/BJ20061548, 1783993, 17238862.
26. Lessard L, Stuible M, Tremblay ML. The two faces of PTP1B in cancer. Biochimica et Biophysica Acta 2010, 1804:613-619.
27. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991, 139:271-279. 10.1016/0022-1759(91)90198-O, 1710634.
28. Chuang TC, Moshir S, Garini Y, Chuang AY, Young IT, Vermolen B, van den Doel R, Mougey V, Perrin M, Braun M, Kerr PD, Fest T, Boukamp P, Mai S. The three-dimensional organization of telomeres in the nucleus of mammalian cells. BMC Biol 2004, 2:12. 10.1186/1741-7007-2-12, 425602, 15176976.
29. Schaefer LH, Schuster D, Herz H. Generalized approach for accelerated maximum likelihood based image restoration applied to three-dimensional fluorescence microscopy. J Microsc 2001, 204:99-107. 10.1046/j.1365-2818.2001.00949.x, 11737543.
30. Vermolen B, Garini Y, Mai S, Mougey V, Fest T, Chuang TC, Chuang AY, Wark L, Young IT. Characterizing the three-dimensional organization of telomeres. Cytometry A 2005, 67:144-150.
31. Poon SS, Martens UM, Ward RK, Lansdorp PM. Telomere length measurements using digital fluorescence microscopy. Cytometry 1999, 36:267-278. 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O, 10404142.
32. Mai S, Garini Y. The significance of telomeric aggregates in the interphase nuclei of tumor cells. J Cell Biochem 2006, 97:904-915. 10.1002/jcb.20760, 16408280.
33. Sarkar R, Guffei A, Vermolen BJ, Garini Y, Mai S. Alterations of centromere positions in nuclei of immortalized and malignant mouse lymphocytes. Cytometry A 2007, 71:386-392.